- Chemiluminescence Immunoassay Analyzers
- Radioimmunoassay Analyzers
- Immunofluorescence Analyzers
- ELISA Analyzers
- Consumable
Immunoassay Analyzers Market size was valued at USD 39.5 billion in 2022, at a CAGR of 5.2% from 2023-29. Immunoassay analyzers are the instruments that are used in clinical settings, hospitals, or maybe research organizations to run biochemical tests to detect the concentration of samples. The market for immune analyzers is growing due to the increased prevalence of disease outbreaks such as Zika and the rising incidence of chronic diseases such as hepatitis. Furthermore, advances in laboratory automation and integration, as well as preventative healthcare, are creating prospects for the global immunoassay analyzers market growth. Immunoassay analyzers are extensively used in clinical laboratories and hospitals to perform biochemical tests aimed at detecting and measuring the quantity of chemicals in samples. Small-scale laboratories have a long time to adjust to changes in instrumentation due to factors such as system revaluation, staff training, procedure standardization, and lengthy purchase processes. Manufacturers, on the other hand, are seeking to make more affordable analyzer systems or provide replacement benefits to create revenue. Companies operating in the global immune analyzers market are focusing on new product developments and launches to strengthen their position.
Key Developments:
- In September 2017 Siemens got a CE Mark and launched its Atellica Solution flexible, scalable, automation-ready immunoassay and chemistry analyzer
- In March 2016, Diasorin S.p.A. entered into the agreement to acquire Quests Focus Diagnostics, Inc.'s molecular diagnostic and immunodiagnostic products business.
- In September 2014, Sysmex Corp. launched an Automated, compact Immunoassay System HISCL 800 for immunochemistry testing for increasingly diverse needs. Furthermore, companies also adapt strategies such as acquisitions and collaboration to increase their product portfolio and market share.
Immunoassay Analyzers Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
5.2%
Largest Market
North America
Fastest Growing Market
Asia-Pacific
Immunoassay Analyzers Market Dynamics
immune analyzers market is primarily driven by adaptation of the automated instruments in the research and other commercial organizations, especially in developed countries. In addition, growing prevalence of the chronic conditions, infectious diseases and R&D investments in biotechnological companies around the world. Furthermore, advancements in the immune analyzers such as advent of portable immune assay analyzers and new product launches are expected to boost the market growth over the forecast period. However, high cost of devices and lack of skilled professionals are expected to hamper the market growth over the forecast period.
North-America Got Significant Share
Immunoassay Analyzers Market Regional Analysis
Geographically, global immuno analyzers market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America immune analyzers market is expected to grow at notable rates owing to the technological advancements and presence of key market players in the region. In addition, recent product launches and collaboration of various organizations in advancing the biotechnology to diagnose and treat diseases projected to boost the market share in the region. For Instance, Abbot Laboratories has launched Automated Immunoassay instrument Architect i1000SR. Europe immune analyzers market projected to have significant market share due to the presence of key market players and adaptation of automated instruments and increased fundings in biotechnological firms. Asia Pacific region projected to have lucrative market growth opportunity owing to the increase in the prevalence of chronic and infectious diseases. The countries such as India and China expected to contribute significant share in regional market owing to increase in the R&D investment by the companies and adaptation of automated instruments in many organizations
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- Immunoassay Analyzers Market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Immunoassay Analyzers Market Segmentation
By Product Type
By Application
- Oncology
- Therapeutic Drug Monitoring
- Cardiology
- Autoimmune Disease
- Infectious Disease Testing
By End User
- Biotechnological Firms
- Research Organizations
- Diagnostic Centers
- Others
Frequently Asked Questions
The immunoassay analyzers market size was valued at USD 39.5 billion in 2022
The immunoassay analyzers market key players are: Abbott BD Beckman Coulter, Inc. Bio-Rad Laboratories, Inc. bioMrieux SA Biokit S.A. DiaSorin S.p.A. Hoffmann-La Roche Ltd. Immunodiagnostic Systems Luminex Corporation Merck KGaA Nova Century Scientific, Inc. Olympus Corporation Ortho Clinical Diagnostics Quidel Corporation Randox Laboratories Ltd. Siemens Tecan Trading AG The Binding Site Group Ltd. Thermo Fisher Scientific, Inc.
The immunoassay analyzers market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Immunoassay Analyzers Market Introduction |
| 2.1.Global Immunoassay Analyzers Market - Taxonomy |
| 2.2.Global Immunoassay Analyzers Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Application |
| 2.2.3.End Users |
| 2.2.4.Region |
| 3. Global Immunoassay Analyzers Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Immunoassay Analyzers Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Immunoassay Analyzers Market By Product Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Chemiluminescence Immunoassay Analyzers |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Radioimmunoassay Analyzers |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Immunofluorescence Analyzers |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. ELISA Analyzers |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Consumable |
| 5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6. Global Immunoassay Analyzers Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Oncology |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Therapeutic Drug Monitoring |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Cardiology |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Autoimmune Disease |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Infectious Disease Testing |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Immunoassay Analyzers Market By End Users, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Biotechnological Firms |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Research Organizations |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Diagnostic Centers |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Immunoassay Analyzers Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America Immunoassay Analyzers Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Chemiluminescence Immunoassay Analyzers |
| 9.1.2.Radioimmunoassay Analyzers |
| 9.1.3.Immunofluorescence Analyzers |
| 9.1.4.ELISA Analyzers |
| 9.1.5.Consumable |
| 9.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Oncology |
| 9.2.2.Therapeutic Drug Monitoring |
| 9.2.3.Cardiology |
| 9.2.4.Autoimmune Disease |
| 9.2.5.Infectious Disease Testing |
| 9.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Biotechnological Firms |
| 9.3.2.Research Organizations |
| 9.3.3.Diagnostic Centers |
| 9.3.4.Others |
| 9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe Immunoassay Analyzers Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Chemiluminescence Immunoassay Analyzers |
| 10.1.2.Radioimmunoassay Analyzers |
| 10.1.3.Immunofluorescence Analyzers |
| 10.1.4.ELISA Analyzers |
| 10.1.5.Consumable |
| 10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Oncology |
| 10.2.2.Therapeutic Drug Monitoring |
| 10.2.3.Cardiology |
| 10.2.4.Autoimmune Disease |
| 10.2.5.Infectious Disease Testing |
| 10.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Biotechnological Firms |
| 10.3.2.Research Organizations |
| 10.3.3.Diagnostic Centers |
| 10.3.4.Others |
| 10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11. Asia Pacific (APAC) Immunoassay Analyzers Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Chemiluminescence Immunoassay Analyzers |
| 11.1.2.Radioimmunoassay Analyzers |
| 11.1.3.Immunofluorescence Analyzers |
| 11.1.4.ELISA Analyzers |
| 11.1.5.Consumable |
| 11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Oncology |
| 11.2.2.Therapeutic Drug Monitoring |
| 11.2.3.Cardiology |
| 11.2.4.Autoimmune Disease |
| 11.2.5.Infectious Disease Testing |
| 11.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Biotechnological Firms |
| 11.3.2.Research Organizations |
| 11.3.3.Diagnostic Centers |
| 11.3.4.Others |
| 11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) Immunoassay Analyzers Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Chemiluminescence Immunoassay Analyzers |
| 12.1.2.Radioimmunoassay Analyzers |
| 12.1.3.Immunofluorescence Analyzers |
| 12.1.4.ELISA Analyzers |
| 12.1.5.Consumable |
| 12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Oncology |
| 12.2.2.Therapeutic Drug Monitoring |
| 12.2.3.Cardiology |
| 12.2.4.Autoimmune Disease |
| 12.2.5.Infectious Disease Testing |
| 12.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Biotechnological Firms |
| 12.3.2.Research Organizations |
| 12.3.3.Diagnostic Centers |
| 12.3.4.Others |
| 12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America Immunoassay Analyzers Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Chemiluminescence Immunoassay Analyzers |
| 13.1.2.Radioimmunoassay Analyzers |
| 13.1.3.Immunofluorescence Analyzers |
| 13.1.4.ELISA Analyzers |
| 13.1.5.Consumable |
| 13.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Oncology |
| 13.2.2.Therapeutic Drug Monitoring |
| 13.2.3.Cardiology |
| 13.2.4.Autoimmune Disease |
| 13.2.5.Infectious Disease Testing |
| 13.3. End Users Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Biotechnological Firms |
| 13.3.2.Research Organizations |
| 13.3.3.Diagnostic Centers |
| 13.3.4.Others |
| 13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Abbott |
| 14.2.2.BD |
| 14.2.3.Beckman Coulter, Inc. |
| 14.2.4.Bio-Rad Laboratories, Inc. |
| 14.2.5.bioMrieux SA |
| 14.2.6.Biokit S.A. |
| 14.2.7.DiaSorin S.p.A. |
| 14.2.8.Hoffmann-La Roche Ltd. |
| 14.2.9.Immunodiagnostic Systems |
| 14.2.10.Luminex Corporation |
| 14.2.11.Merck KGaA |
| 14.2.12.Nova Century Scientific, Inc. |
| 14.2.13.Olympus Corporation |
| 14.2.14.Ortho Clinical Diagnostics |
| 14.2.15.Quidel Corporation |
| 14.2.16.Randox Laboratories Ltd. |
| 14.2.17.Siemens |
| 14.2.18.Tecan Trading AG |
| 14.2.19.The Binding Site Group Ltd. |
| 14.2.20.Thermo Fisher Scientific, Inc. |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Abbott
- BD
- Beckman Coulter, Inc.
- Bio-Rad Laboratories, Inc.
- bioMrieux SA
- Biokit S.A.
- DiaSorin S.p.A.
- Hoffmann-La Roche Ltd.
- Immunodiagnostic Systems
- Luminex Corporation
- Merck KGaA
- Nova Century Scientific, Inc.
- Olympus Corporation
- Ortho Clinical Diagnostics
- Quidel Corporation
- Randox Laboratories Ltd.
- Siemens
- Tecan Trading AG
- The Binding Site Group Ltd.
- Thermo Fisher Scientific, Inc.